Yoshino A - Search Results

1

Antitumor effect of lenalidomide in malignant glioma cell lines.

Hanashima Y, Sano E, Sumi K, Ozawa Y, Yagi C, Tatsuoka J, Yoshimura S, Yamamuro S, Ueda T, Nakayama T, Hara H, Yoshino A. Hanashima Y, et al. Among authors: yoshino a. Oncol Rep. 2020 May;43(5):1580-1590. doi: 10.3892/or.2020.7543. Epub 2020 Mar 12. Oncol Rep. 2020. PMID: 32323826 Free PMC article.

2

Control of proliferation and survival of C6 glioma cells with modification of the nerve growth factor autocrine system.

Watanabe T, Katayama Y, Kimura S, Yoshino A. Watanabe T, et al. Among authors: yoshino a. J Neurooncol. 1999 Jan;41(2):121-8. doi: 10.1023/a:1006127624487. J Neurooncol. 1999. PMID: 10222432

3

Growth control of C6 glioma in vivo by nerve growth factor.

Kimura S, Yoshino A, Katayama Y, Watanabe T, Fukushima T. Kimura S, et al. Among authors: yoshino a. J Neurooncol. 2002 Sep;59(3):199-205. doi: 10.1023/a:1019919019497. J Neurooncol. 2002. PMID: 12241115

4

Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence.

Yoshino A, Katayama Y, Fukushima T, Watanabe T, Komine C, Yokoyama T, Kusama K, Moro I. Yoshino A, et al. J Neurooncol. 2003 Jun;63(2):155-62. doi: 10.1023/a:1023935621976. J Neurooncol. 2003. PMID: 12825819

5

Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.

Yoshino A, Katayama Y, Yokoyama T, Watanabe T, Ogino A, Ota T, Komine C, Fukushima T, Kusama K. Yoshino A, et al. J Neurooncol. 2005 Sep;74(3):249-60. doi: 10.1007/s11060-004-7316-1. J Neurooncol. 2005. PMID: 16187022

6

Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas.

Ohta T, Watanabe T, Katayama Y, Yoshino A, Yachi K, Ogino A, Komine C, Fukushima T. Ohta T, et al. Among authors: yoshino a. Oncol Rep. 2006 Nov;16(5):957-63. Oncol Rep. 2006. PMID: 17016577

7

Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.

Yoshino A, Katayama Y, Ogino A, Watanabe T, Yachi K, Ohta T, Komine C, Yokoyama T, Fukushima T. Yoshino A, et al. J Neurooncol. 2007 Jun;83(2):153-62. doi: 10.1007/s11060-006-9316-9. Epub 2007 Jan 11. J Neurooncol. 2007. PMID: 17216555

8

Effect of IFN-beta on human glioma cell lines with temozolomide resistance.

Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E. Yoshino A, et al. Int J Oncol. 2009 Jul;35(1):139-48. doi: 10.3892/ijo_00000322. Int J Oncol. 2009. PMID: 19513561

9

Hemangiopericytoma arising in the body of the lateral ventricle.

Sumi K, Watanabe T, Ohta T, Fukushima T, Kano T, Yoshino A, Katayama Y. Sumi K, et al. Among authors: yoshino a. Acta Neurochir (Wien). 2010 Jan;152(1):145-9; discussion 150. doi: 10.1007/s00701-009-0348-8. Acta Neurochir (Wien). 2010. PMID: 19730782

10

Gene expression profiling predicts response to temozolomide in malignant gliomas.

Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E, Tsumoto K. Yoshino A, et al. Int J Oncol. 2010 Jun;36(6):1367-77. doi: 10.3892/ijo_00000621. Int J Oncol. 2010. PMID: 20428759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

535 results

Search Page

Filters